Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oceanside Pharmaceuticals is a specialty pharmaceutical company and a subsidiary of Bausch Health. The company focuses on the commercialization and distribution of authorized generic versions of branded pharmaceutical products, primarily those within the Bausch Health portfolio. By offering authorized generics, Oceanside provides patients with cost-effective access to medications that are identical in formulation and quality to their branded counterparts. Its product line covers a wide range of therapeutic areas, including neurology, dermatology, ophthalmology, and gastrointestinal health. Oceanside plays a strategic role in the lifecycle management of its parent company's assets by maintaining market share after patent expirations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oceanside.